Oxidative and nitrosative modifications of biliverdin reductase-a in the brain of subjects with alzheimer's disease and amnestic mild cognitive impairment

Journal of Alzheimer's Disease

Volumn 25, Issue 4, 2011, Pages 623-633

  Barone, Eugenio ^a,b   Di Domenico, Fabio ^a,c   Cenini, Giovanna ^a   Sultana, Rukhsana ^a   Coccia, Raffaella ^c   Preziosi, Paolo ^b   Perluigi, Marzia ^c   Mancuso, Cesare ^b   Butterfield, D Allan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b CATHOLIC UNIVERSITY   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alzheimer's disease; biliverdin reductase; heme oxygenase; mild cognitive impairment; neurodegenerative disorders; oxidative stress

Indexed keywords

4 HYDROXYNONENAL; ACTIVATED PROTEIN C; BILIVERDIN; BILIVERDIN REDUCTASE A; GLUCOSE; HEME OXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; CELL PROLIFERATION; CELLULAR STRESS RESPONSE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HIPPOCAMPUS; HOMEOSTASIS; HUMAN; HUMAN TISSUE; MALE; MILD COGNITIVE IMPAIRMENT; NITROSATIVE STRESS; OXIDATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN MODIFICATION; UPREGULATION;

EID: 80052829260     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110092     Document Type: Article

References (75)

1. Maines MD, Panahian N (2001) The heme oxygenase system and cellular defense mechanisms. Do HO-1 and HO-2 have different functions? Adv Exp Med Biol 502, 249-272. (Pubitemid 34234060)
2. Maines MD (1997) The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37, 517-554. (Pubitemid 27238886)
3. Maines MD (2000) The heme oxygenase system and its functions in the brain. Cell Mol Biol (Noisy-le-grand) 46, 573-585.
4. Mancuso C (2004) Heme oxygenase and its products in the nervous system. Antioxid Redox Signal 6, 878-887. (Pubitemid 39237941)
5. Dwyer BE, Nishimura RN, Lu SY (1995) Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody. Response to oxidative stress. Brain Res Mol Brain Res 30, 37-47.
6. Kapitulnik J, Maines MD (2009) Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cyto-protective and cytotoxic bilirubin. Trends Pharmacol Sci 30, 129-137.
7. Maines MD (2005) New insights into biliverdin reductase functions: linking heme metabolism to cell signaling. Physiology (Bethesda) 20, 382-389. (Pubitemid 41812421)
8. Franklin EM, Browne S, Horan AM, Inomata K, Ham-mam MA, Kinoshita H, Lamparter T, Golfis G, Mantle TJ (2009) The use of synthetic linear tetrapyrroles to probe the verdin sitesofhuman biliverdin-IXalpha reductase and human biliverdin-IXbeta reductase. FEBS J 276, 4405-4413.
9. Ewing JF, Weber CM, Maines MD (1993) Biliverdin reduc-tase is heat resistant and coexpressed with constitutive and heat shock forms of heme oxygenase in brain. J Neurochem 61, 1015-1023. (Pubitemid 23241240)
10. Mancuso C, Barone E (2009) The heme oxygenase/biliverdin reductase pathway in drug research and development. Curr Drug Metab 10, 579-594.
11. Errico S, Shohreh R, Barone E, Pusateri A, Mores N, Man-cuso C (2010) Heme oxygenase-derived carbon monoxide modulates gonadotropin-releasing hormone releaseinimmor-talized hypothalamic neurons. Neurosci Lett 471, 175-178.
12. Mancuso C, Navarra P, Preziosi P (2010) Rolesofnitric oxide, carbon monoxide, and hydrogen sulfide in the regulation of the hypothalamic-pituitary- adrenal axis. J Neurochem 113, 563-575.
13. Navarra P, Dello Russo C, Mancuso C, Preziosi P, Grossman A (2000) Gaseous neuromodulators in the control of neuroendocrine stress axis. Ann N Y Acad Sci 917, 638-646.
14. Mancuso C, Preziosi P, Grossman AB, Navarra P (1997) The role of carbon monoxide in the regulation of neuroendocrine function. Neuroimmunomodulation 4, 225-229. (Pubitemid 28231583)
15. Mancuso C, Tringali G, Grossman A, Preziosi P, Navarra P (1998) The generation of nitric oxide and carbon monoxide produces opposite effects on the release of immunoreactive interleukin-1 beta from the rat hypothalamus in vitro: evidence for the involvement of different signaling pathways. Endocrinology 139, 1031-1037. (Pubitemid 28510120)
16. Mancuso C, Kostoglou-Athanassiou I, Forsling ML, Grossman AB, Preziosi P, Navarra P, Minotti G (1997) Activation of heme oxygenase and consequent carbon monoxide formation inhibits the release of arginine vasopressin from rat hypotha-lamic explants. Molecular linkage between heme catabolism and neuroendocrine function. Brain Res Mol Brain Res 50, 267-276. (Pubitemid 27488915)
17. Mancuso C, Pistritto G, Tringali G, Grossman AB, Preziosi P, Navarra P (1997) Evidence that carbon monoxide stimulates prostaglandin endoperoxide synthase activity in rat hypotha-lamic explants and in primary cultures of rat hypothalamic astrocytes. Brain Res Mol Brain Res 45, 294-300. (Pubitemid 27170706)
18. Pozzoli G, Mancuso C, Mirtella A, Preziosi P, Grossman AB, Navarra P (1994) Carbon monoxideasanovel neuroendocrine modulator: inhibition of stimulated corticotropin-releasing hormone release from acute rat hypothalamic explants. Endocrinology 135, 2314-2317. (Pubitemid 24377382)
19. Fetoni AR, Mancuso C, Eramo SL, Ralli M, Piacentini R, Barone E, Paludetti G, Troiani D (2010) In vivo protective effect of ferulic acid against noise-induced hearing loss in the guinea-pig. Neuroscience 169, 1575-1588.
20. Barone E, Trombino S, Cassano R, Sgambato A, De Paola B, Di Stasio E, Picci N, Preziosi P, Mancuso C (2009) Characterization of the S-denitrosylating activity of bilirubin. J Cell Mol Med 13, 2365-2375.
21. Mancuso C, Bonsignore A, Capone C, Di Stasio E, Pani G (2006) Albumin-bound bilirubin interacts with nitric oxide by a redox mechanism. Antioxid Redox Signal 8, 487-494. (Pubitemid 43741317)
22. Mancuso C, Bonsignore A, Di Stasio E, Mordente A, Mot-terlini R (2003) Bilirubin and S-nitrosothiols interaction: evidence for a possible role of bilirubin as a scavenger of nitric oxide. Biochem Pharmacol 66, 2355-2363. (Pubitemid 37456743)
23. Mancuso C, Capone C, Ranieri SC, Fusco S, Calabrese V, Eboli ML, Preziosi P, Galeotti T, Pani G (2008) Bilirubin as an endogenous modulator of neurotrophin redox signaling. J Neurosci Res 86, 2235-2249.
24. Mancuso C, Pani G, Calabrese V (2006) Bilirubin: an endogenous scavenger of nitric oxide and reactive nitrogen species. Redox Rep 11, 207-213. (Pubitemid 44741627)
25. Palozza P, Serini S, Curro D, Calviello G, Igarashi K, Man-cuso C (2006) beta-Carotene and cigarette smoke condensate regulate heme oxygenase-1 and its repressor factor Bach1: relationship with cell growth. Antioxid Redox Signal 8, 1069-1080. (Pubitemid 44036523)
26. Poon HF, Calabrese V, Scapagnini G, Butterfield DA (2004) Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress. J Gerontol A Biol Sci Med Sci 59, 478-493. (Pubitemid 38649940)
27. Schipper HM, Song W, Zukor H, Hascalovici JR, Zelig-man D (2009) Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement. J Neurochem 110, 469-485.
28. Minotti G, Aust SD (1987) The requirement for iron (III) in the initiation of lipid peroxidation by iron (II) and hydrogen peroxide. J Biol Chem 262, 1098-1104. (Pubitemid 17028419)
29. Schipper HM, Cisse S, Stopa EG (1995) Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann Neurol 37, 758-768.
30. Schipper HM, Bennett DA, Liberman A, Bienias JL, Schneider JA, Kelly J, Arvanitakis Z (2006) Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging 27, 252-261. (Pubitemid 43038549)
31. Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM (2007) Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 8, 766-775. (Pubitemid 47462116)
32. Mancuso C, Scapagini G, Curro D, Giuffrida Stella AM, De Marco C, Butterfield DA, Calabrese V (2007) Mitochon-drial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. Front Biosci 12, 1107-1123. (Pubitemid 46846882)
33. Calabrese V, Sultana R, Scapagnini G, Guagliano E, Sapienza M, Bella R, Kanski J, Pennisi G, Mancuso C, Stella AM, But-terfield DA (2006) Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease. Antioxid Redox Signal 8, 1975-1986. (Pubitemid 46489625)
34. Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23, 134-147. (Pubitemid 27217017)
35. Butterfield DA, Lauderback CM (2002) Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic Biol Med 32, 1050-1060. (Pubitemid 34603342)
36. Smith MA, Perry G, Pryor WA (2002) Causes and conse-quencesofoxidative stressin Alzheimer's disease.Free Radic Biol Med 32, 1049. (Pubitemid 34603341)
37. Kimpara T, Takeda A, Yamaguchi T, Arai H, Okita N, Takase S, Sasaki H, Itoyama Y (2000) Increased bilirubins and their derivatives incerebrospinal fluidin Alzheimer's disease. Neu-robiol Aging 21, 551-554. (Pubitemid 30621493)
38. Salim M, Brown-Kipphut BA, Maines MD (2001) Human biliverdin reductase is autophosphorylated, and phosphory-lation is required for bilirubin formation. J Biol Chem 276, 10929-10934. (Pubitemid 38089271)
39. Lerner-Marmarosh N, Shen J, Torno MD, Kravets A, Hu Z, Maines MD (2005) Human biliverdin reductase: a member of the insulin receptor substrate family with ser-ine/threonine/tyrosine kinase activity. Proc Natl Acad Sci USA 102, 7109-7114. (Pubitemid 40696342)
40. Lerner-Marmarosh N, Miralem T, Gibbs PE, Maines MD (2008) Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling. Proc Natl Acad Sci USA 105, 6870-6875. (Pubitemid 351754497)
41. Barone E, Di Domenico F, Cenini G, Sultana R, Cini C, Preziosi P, Perluigi M, Mancuso C, Butterfield DA (2011) Biliverdin reductase-a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment. Biochim Biophys Acta, 1812, 480-487.
42. Perluigi M, Sultana R, Cenini G, Di Domenico F, Memo M, Pierce WM, Coccia R, Butterfield DA (2009) Redox pro-teomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis. Proteomics Clin Appl 3, 682-693.
43. Sultana R, Butterfield DA (2009) Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment. J Bioenerg Biomembr 41, 441-446.
44. Sultana R, Perluigi M, Newman SF, Pierce WM, Cini C, Coc-cia R, Butterfield DA (2010) Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease. Antioxid Redox Signal 12, 327-336.
45. Reed T, Perluigi M, Sultana R, Pierce WM, Klein JB, Turner DM, Coccia R, Markesbery WR, Butterfield DA (2008) Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neuro-biol Dis 30, 107-120.
46. Butterfield DA, Reed TT, Perluigi M, De Marco C, Coccia R, Keller JN, Markesbery WR, Sultana R (2007) Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease. Brain Res 1148, 243-248. (Pubitemid 46602178)
47. Butterfield DA, Abdul HM, Opii W, Newman SF, Joshi G, Ansari MA, Sultana R (2006) Pin1 in Alzheimer's disease. J Neurochem 98, 1697-1706. (Pubitemid 44298238)
48. Sultana R, Poon HF, Cai J, Pierce WM, Merchant M, Klein JB, Markesbery WR, Butterfield DA (2006) Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol Dis 22, 76-87.
49. Castegna A, Thongboonkerd V, Klein JB, Lynn B, Markes-bery WR, Butterfield DA (2003) Proteomic identification of nitrated proteins in Alzheimer's disease brain. J Neurochem 85, 1394-1401. (Pubitemid 36702552)
50. Cenini G, Sultana R, Memo M, Butterfield DA (2008) Effects of oxidative and nitrosative stressin brainonp53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease. Free Radic Biol Med 45, 81-85.
51. Petersen RC (2003) Mild cognitive impairment clinical trials. Nat Rev Drug Discov 2, 646-653. (Pubitemid 37361768)
52. Jicha GA, Parisi JE, Dickson DW, Johnson K, Cha R, Ivnik RJ, Tangalos EG, Boeve BF, Knopman DS, Braak H, Petersen RC (2006) Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Arch Neurol 63, 674-681.
53. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944. (Pubitemid 14076461)
54. Conrad CC, Talent JM, Malakowsky CA, Gracy RW (2000) Post-Electrophoretic Identification of Oxidized Proteins. Biol Proced Online 2, 39-45.
55. Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Aksenov M, Aksenova M, Gabbita SP, Wu JF, Carney JM, et al. (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkersofprotein oxidation. J Neurochem 65, 2146-2156.
56. Yatin SM, Aksenova M, Aksenov M, Markesbery WR, Aulick T, Butterfield DA (1998) Temporal relations among amyloid beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses. J Mol Neurosci 11, 183-197. (Pubitemid 29232849)
57. Butterfield DA, Yatin SM, Varadarajan S, Koppal T (1999) Amyloid beta-peptide-associated free radical oxidative stress, neurotoxicity, and Alzheimer's disease. Methods Enzymol 309, 746-768. (Pubitemid 29446485)
58. Yatin SM, Varadarajan S, Link CD, Butterfield DA (1999) In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42). Neurobiol Aging 20, 325-330; discussion 339-342. (Pubitemid 29525418)
59. Sultana R, Butterfield DA (2004) Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products. Neu-rochem Res 29, 2215-2220. (Pubitemid 40036893)
60. Sultana R, Boyd-Kimball D, Poon HF, Cai J, Pierce WM, Klein JB, Markesbery WR, Zhou XZ, Lu KP, Butterfield DA (2006) Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis. Neurobiol Aging 27, 918-925.
61. Sultana R, Boyd-Kimball D, Poon HF, Cai J, Pierce WM, Klein JB, Merchant M, Markesbery WR, Butterfield DA (2006) Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiol Aging 27, 1564-1576. (Pubitemid 44344840)
62. Butterfield DA, Reed T, Perluigi M, De Marco C, Coccia R, Cini C, Sultana R (2006) Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Neurosci Lett 397, 170-173.
63. Butterfield DA, Poon HF, St Clair D, Keller JN, Pierce WM, Klein JB, Markesbery WR (2006) Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol Dis 22, 223-232.
64. Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, But-terfield DA, Markesbery WR (2005) Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 64, 1152-1156.
65. Markesbery WR (2010) Neuropathologic alterations in mild cognitive impairment: a review. J Alzheimers Dis19, 221-228.
66. Aksenov M, Aksenova MV, Harris ME, Hensley K, Butter-field DA, Carney JM (1995) Enhancement of beta-amyloid peptide A beta (1-40)-mediated neurotoxicity by glutamine synthetase. J Neurochem 65, 1899-1902.
67. Lu N, Zhang Y, Li H, Gao Z (2010) Oxidative and nitra-tive modifications of alpha-enolase in cardiac proteins from diabetic rats. Free Radic Biol Med 48, 873-881.
68. Gao P, Song Y, Li H, Gao Z (2009) Efficiency of methe-moglobin, hemin and ferric citrate in catalyzing protein tyrosine nitration, protein oxidation and lipid peroxidation in a bovine serum albumin-liposome system: influence of pH. J Inorg Biochem 103, 783-790.
69. Stamler JS, Singel DJ, Loscalzo J (1992) Biochemistry of nitric oxide and its redox-activated forms. Science 258, 1898-1902. (Pubitemid 23026727)
70. Hogg N, Darley-Usmar VM, Wilson MT, Moncada S (1992) Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J 281 (Pt 2), 419-424.
71. Huie RE, Padmaja S (1993) The reaction of no with superox-ide. Free Radic Res Commun 18, 195-199.
72. Ewing JF, Maines MD (1995) Immunohistochemical localization of biliverdin reductase in rat brain: age related expression of protein and transcript. Brain Res 672, 29-41.
73. Perez N, Sugar J, Charya S, Johnson G, Merril C, Bierer L, Perl D, Haroutunian V, Wallace W (1991) Increased synthesis and accumulation of heat shock 70 proteins in Alzheimer's disease. Brain Res Mol Brain Res 11, 249-254.
74. Premkumar DR, Smith MA, Richey PL, Petersen RB, Castel-lani R, Kutty RK, Wiggert B, Perry G, Kalaria RN (1995) Induction of heme oxygenase-1 mRNA and protein in neocor-tex and cerebral vessels in Alzheimer's disease. J Neurochem 65, 1399-1402.
75. Di Domenico F, Sultana R, Tiu GF, Scheff NN, Perluigi M, Cini C, Butterfield DA (2010) Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease. Brain Res 1333, 72-81.